BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34668049)

  • 1. Congenital hyperinsulinism: localization of a focal lesion with
    States LJ; Becker SA; De León DD
    Pediatr Radiol; 2022 Apr; 52(4):693-701. PubMed ID: 34668049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18-F-L 3,4-Dihydroxyphenylalanine PET/Computed Tomography in the Management of Congenital Hyperinsulinism.
    States LJ; Saade-Lemus S; De Leon DD
    PET Clin; 2020 Jul; 15(3):349-359. PubMed ID: 32498990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
    Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K
    J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    States LJ; Davis JC; Hamel SM; Becker SA; Zhuang H
    J Nucl Med; 2021 Jul; 62(Suppl 2):51S-56S. PubMed ID: 34230074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
    Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
    J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Focal congenital hyperinsulinism].
    Tallós Z; Luczay A; Balogh L; Méder Ü; Várkonyi I; Seszták T; Borka K; Harsányi L; Kálmán A
    Orv Hetil; 2023 Nov; 164(47):1877-1884. PubMed ID: 38007812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism.
    Ismail D; Hussain K
    Rev Endocr Metab Disord; 2010 Sep; 11(3):165-9. PubMed ID: 20878481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
    Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J
    Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism.
    Yang J; Yuan L; Meeks JK; Zhang N; Li C; Hao R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):619-22. PubMed ID: 23155683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.
    Ribeiro MJ; Boddaert N; Bellanné-Chantelot C; Bourgeois S; Valayannopoulos V; Delzescaux T; Jaubert F; Nihoul-Fékété C; Brunelle F; De Lonlay P
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2120-8. PubMed ID: 17661030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
    Hardy OT; Hernandez-Pampaloni M; Saffer JR; Suchi M; Ruchelli E; Zhuang H; Ganguly A; Freifelder R; Adzick NS; Alavi A; Stanley CA
    J Pediatr; 2007 Feb; 150(2):140-5. PubMed ID: 17236890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital hyperinsulinism treated by surgical resection of the hyperplastic lesion which had been preoperatively diagnosed by 18F-DOPA PET examination in Japan: a nationwide survey.
    Kanamori Y; Watanabe T; Yorifuji T; Masue M; Sasaki H; Nio M
    Pediatr Surg Int; 2018 Oct; 34(10):1093-1098. PubMed ID: 30076450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis of ectopic focal hyperinsulinism of infancy with [18F]-dopa positron emission tomography.
    Hussain K; Seppänen M; Näntö-Salonen K; Adzick NS; Stanley CA; Thornton P; Minn H
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2839-42. PubMed ID: 16684819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital hyperinsulinism : contributions of chemistry, therapeutic response, genetics and imaging].
    Vandendaele C; Kaschten S; Parent AS; Fudvoye J
    Rev Med Liege; 2024 Mar; 79(3):168-174. PubMed ID: 38487911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism.
    Garg PK; Putegnat B; Truong L; Reynolds C; Sanchez I; Nedrelow JK; Uffman J; Lokitz SJ; Nazih R; Garg S; Thornton PS
    PLoS One; 2020; 15(10):e0241243. PubMed ID: 33108363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A compound heterozygous mutation of ABCC8 gene causing a diazoxide-unresponsive congenital hyperinsulinism with an atypical form: Not a focal lesion in the pancreas reported by ¹⁸F-DOPA-PET/CT scan.
    Zhang W; Liu L; Wen Z; Cheng J; Li C; Li X; Niu H; Wang F; Sheng H; Liu H
    Gene; 2015 Nov; 572(2):222-6. PubMed ID: 26162674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.
    Ribeiro MJ; De Lonlay P; Delzescaux T; Boddaert N; Jaubert F; Bourgeois S; Dollé F; Nihoul-Fékété C; Syrota A; Brunelle F
    J Nucl Med; 2005 Apr; 46(4):560-6. PubMed ID: 15809476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.
    Capito C; Khen-Dunlop N; Ribeiro MJ; Brunelle F; Aigrain Y; Crétolle C; Jaubert F; De Lonlay P; Nihoul-Fékété C
    Radiology; 2009 Oct; 253(1):216-22. PubMed ID: 19709999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography in congenital hyperinsulinism.
    Mathur NB; Sharma M; Agarwal A; Kumar A
    Indian Pediatr; 2011 Feb; 48(2):139-41. PubMed ID: 21378423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heterogeneity of focal forms of congenital hyperinsulinism.
    Ismail D; Kapoor RR; Smith VV; Ashworth M; Blankenstein O; Pierro A; Flanagan SE; Ellard S; Hussain K
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E94-9. PubMed ID: 22031516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.